Reta
Research Peptide
Reta (Retatrutide) is a triple GIP/GLP-1/glucagon receptor agonist studied in metabolic and energy-balance research models.
Product Overview
Reta (Retatrutide) is a triple agonist peptide engineered to act at the GIP, GLP-1, and glucagon receptors. It is a reference compound in metabolic-research models studying energy expenditure, glucose handling, and lipid metabolism.
NexGenResearch supplies Reta in a 20mg size, synthesized to analytical purity and independently third-party tested, with a lot-matched Certificate of Analysis available before purchase.
Research Applications
- Studied as a triple GIP/GLP-1/glucagon receptor agonist
- Investigated in energy-expenditure and glucose-handling research
- Used in lipid-metabolism research models
- Compared against single- and dual-agonist reference compounds
Compound Specifications
| Purity | ≥99% (HPLC-UV Verified) |
|---|---|
| Appearance | White lyophilized powder |
| Format | Lyophilized powder, vial |
Storage & Handling
Store lyophilized material at -20°C, protected from light and moisture. Once reconstituted, refrigerate at 2–8°C and use within the timeframe noted on the product COA.
COA & Downloads
No Certificate of Analysis is on file for this product yet. Request one and our team will send it directly.
Request COARelated products
-
Read MoreTirzepatide
$40.00
